Fosfomycin Tromethamine Granules for Oral Solution — Class II drug recall D-0014-2027
Ongoing recall by Cipla USA, Inc., reported 2026-10-14, distributed nationwide. Failed Impurities/Degradation Specifications
| Recall number | D-0014-2027 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Cipla USA, Inc., Warren, NJ, United States |
| Recall initiated | 2026-09-18 |
| Classified | 2026-10-06 |
| Reported by FDA | 2026-10-14 |
| Distributed | Nationwide (US) |
| Reason classes | specification failure |
| NDC | 69097-0579, 69097-0579-67 |
| Lot numbers | 5KA0405 |
| Expiration dates | 2026-12-31 |
Product
Fosfomycin Tromethamine Granules for Oral Solution, (Equivalent to 3 Grams of Fosfomycin), 1 Single-Dose Sachet, Rx only, Manufactured by: Cipla Ltd., Kurkumbh-413802, Maharashtra, India, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059, NDC 69097-579-67.
Reason for recall
Failed Impurities/Degradation Specifications
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0014-2027. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-10-21. Not affiliated with or endorsed by FDA. Not medical or legal advice.